Successful switch to sitaxsentan in a patient with HIV-related pulmonary arterial hypertension and late intolerance to nonselective endothelin receptor blockade

Therapeutic Advances in Respiratory Disease

Volumn 3, Issue 1, 2009, Pages 11-14

  Zacà, Valerio ^a   Metra, Marco ^a   Danesi, Rossella ^a   Lombardi, Carlo ^a   Verzura, Giulia ^a   Dei Cas, Livio ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

endothelin receptor antagonists; HIV infection; pulmonary arterial hypertension; sitaxsentan

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ASPARTATE AMINOTRANSFERASE; ATAZANAVIR; BOSENTAN; DECONGESTIVE AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; LAMIVUDINE; PROSTACYCLIN; SITAXSENTAN; TENOFOVIR;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEART CATHETERIZATION; HEMODYNAMICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LUNG ARTERY PRESSURE; LUNG WEDGE PRESSURE; MALE; NOSE CONGESTION; PHYSICAL DISABILITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SINUS CONGESTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; ISOXAZOLES; MALE; MIDDLE AGED; PULMONARY WEDGE PRESSURE; RECEPTORS, ENDOTHELIN; THIOPHENES;

EID: 63049134878     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465808101549     Document Type: Article

References (15)

1. Archer, S. and Rich, S. (2000) Primary pulmonary hypertension: a vascular biology and translational research ‘work in progress’, Circulation 102: 2781-2791.
2. Barst, R.J., Langleben, D., Badesch, D., Frost, A., Lawrence, E.C., Shapiro, S. et al. for the STRIDE-2 Study Group (2006) Treatment of pulmonary arterial hypertension with the selective endothelin-A antagonist sitaxsentan, J Am Coll Cardiol 47: 2049-2056.
3. Barst, R.J., Langleben, D., Frost, A., Horn, E.M., Oudiz, R., Shapiro, S. et al. for the STRIDE-1 Study Group (2004) Sitaxsentan therapy for pulmonary arterial hypertension, Am J Resp Crit Care Med 169: 441-447.
4. Channick, R.N., Simonneau, G., Sitbon, O., Robbins, I.M., Frost, A., Tapson, V.F. et al. (2001) Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled study, Lancet 358: 1119-1123.
5. Galiè, N., Torbicki, A., Barst, R., Dartevelle, P., Haworth, S., Higenbottam, T. et al. (2004) The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Guidelines on diagnosis and treatment of pulmonary arterial hypertension, Eur Heart J 25: 2243-2278.
6. Humbert, M., Morrel, N.W., Archer, S.L., Stenmark, K.R., MacLean, M.R., Lang, I.M. et al. (2004) Cellular and molecular pathobiology of pulmonary arterial hypertension, J Am Coll Cardiol 43: 13S-24S.
7. Kedzierski, R.M. and Yanagisawa, M. (2001) Endothelin system: the double-edged sword in health and disease, Ann Rev Pharmacol Toxicol 41: 851-876.
8. Masaki, T., Yanagisawa, M. and Goto, K. (1992) Physiology and pharmacology of endothelins, Med Res Rev 12: 391-421.
9. Mesa, R.A., Edell, E.S., Dunn, W.F. and Edwards, W.D. (1998) Human immunodeficiency virus infection and pulmonary hypertension: two new cases and a review of 86 reported cases, Mayo Clin Proc 73: 37-45.
10. Mehta, N.J., Khan, I.A., Mehta, R.N. and Sepkowitz, D.A. (2000) HIV-related pulmonary hypertension: analytic review of 131 cases, Chest 118: 1133-1141.
11. Pellicelli, A.M., Barbaro, G., Palmieri, F., Girardi, E., D’ Ambrosio, C., Rianda, A. et al. (2001) Primary pulmonary hypertension in HIV patients: a systematic review, Angiology 52: 31-41.
12. Rubin, L.J., Badesch, D.B., Barst, R.J., Galie, N., Black, C.M., Keogh, A. et al. (2002) Bosentan therapy for pulmonary arterial hypertension, N Engl J Med 346: 896-903.
13. Simonneau, G., Galiè, N., Rubin, L.J., Langleben, D., Seeger, W., Domenighetti, G. et al. (2004) Clinical classification of pulmonary hypertension, J Am Coll Cardiol 43: 5S-12S.
14. Sitbon, O., Gressin, V., Speich, R., Macdonald, P.S., Opravil, M., Cooper, D.A. et al. (2004) Bosentan for the treatment of human immunodeficiency virus-associated pulmonary arterial hypertension, Am J Resp Crit Care Med 170: 1212-1217.
15. Sitbon, O., Gressin, V., Speich, R., Macdonald, P.S., Opravil, M., Cooper, D.A. et al. (1991) Primary pulmonary hypertension in HIV infection, Chest 100: 1268-1271.